Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 18, 2013The LancetOpen Access

Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trial

View Full Paper
Ask AI
Bookmark
Share

Authors

UCUsha ChakravarthyQueen's University BelfastSHSimon HardingUK BiobankCRChris RogersUniversity of Bergamo

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Chakravarthy et al. (2013) studied this question.

synapsesocial.com/papers/6aa23abe01abe00586efa507https://doi.org/10.1016/s0140-6736(13)61501-9
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1SHORT-TERM SAFETY AND EFFICACY OF INTRAVITREAL BEVACIZUMAB (AVASTIN) FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION2006 · 488 citations
  2. 2Macular degeneration: do conventional measurements of impaired visual function equate with visual disability?2000 · 158 citations
  3. 3Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients1994 · 3,136 citations